Literature DB >> 11431331

DNA damage-activated kinase Chk2 is independent of proliferation or differentiation yet correlates with tissue biology.

C Lukas1, J Bartkova, L Latella, J Falck, N Mailand, T Schroeder, M Sehested, J Lukas, J Bartek.   

Abstract

The Chk2 kinase is a tumor suppressor and key transducer of DNA-damage checkpoints. We show that the human Chk2 protein is relatively stable, nuclear, and responding to gamma-radiation throughout the cell cycle. Contrary to the retinoblastoma protein-regulated, labile Chk1 kinase restricted to S-G(2) phases, Chk2 remains activatable even in quiescent and differentiating cells. In human tissues, Chk2 is homogeneously expressed in renewing cell populations such as epidermis or intestine, heterogeneous in conditionally renewing tissues, and absent or cytoplasmic in static tissues such as muscle or brain. These data highlight striking differences between Chk2 and Chk1 and show unexpected correlation of Chk2 expression with tissue biology.

Entities:  

Mesh:

Substances:

Year:  2001        PMID: 11431331

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  36 in total

1.  A CHEK2 genetic variant contributing to a substantial fraction of familial breast cancer.

Authors:  Pia Vahteristo; Jirina Bartkova; Hannaleena Eerola; Kirsi Syrjäkoski; Salla Ojala; Outi Kilpivaara; Anitta Tamminen; Juha Kononen; Kristiina Aittomäki; Päivi Heikkilä; Kaija Holli; Carl Blomqvist; Jiri Bartek; Olli-P Kallioniemi; Heli Nevanlinna
Journal:  Am J Hum Genet       Date:  2002-07-28       Impact factor: 11.025

2.  DNA damage response by single-strand breaks in terminally differentiated muscle cells and the control of muscle integrity.

Authors:  P Fortini; C Ferretti; B Pascucci; L Narciso; D Pajalunga; E M R Puggioni; R Castino; C Isidoro; M Crescenzi; E Dogliotti
Journal:  Cell Death Differ       Date:  2012-06-15       Impact factor: 15.828

3.  Activation of checkpoint kinase 2 by 3,3'-diindolylmethane is required for causing G2/M cell cycle arrest in human ovarian cancer cells.

Authors:  Prabodh K Kandala; Sanjay K Srivastava
Journal:  Mol Pharmacol       Date:  2010-05-05       Impact factor: 4.436

4.  Spontaneous abrogation of the G₂DNA damage checkpoint has clinical benefits but promotes leukemogenesis in Fanconi anemia patients.

Authors:  Raphael Ceccaldi; Delphine Briot; Jérôme Larghero; Nadia Vasquez; Catherine Dubois d'Enghien; Delphine Chamousset; Maria-Elena Noguera; Quinten Waisfisz; Olivier Hermine; Corinne Pondarre; Thierry Leblanc; Eliane Gluckman; Hans Joenje; Dominique Stoppa-Lyonnet; Gérard Socié; Jean Soulier
Journal:  J Clin Invest       Date:  2010-12-22       Impact factor: 14.808

5.  Patterns of DNA damage response in intracranial germ cell tumors versus glioblastomas reflect cell of origin rather than brain environment: implications for the anti-tumor barrier concept and treatment.

Authors:  Jirina Bartkova; Christina E Hoei-Hansen; Katerina Krizova; Petra Hamerlik; Niels E Skakkebæk; Ewa Rajpert-De Meyts; Jiri Bartek
Journal:  Mol Oncol       Date:  2014-07-09       Impact factor: 6.603

Review 6.  S-phase-coupled apoptosis in tumor suppression.

Authors:  Yong-Jig Cho; Peng Liang
Journal:  Cell Mol Life Sci       Date:  2011-03-25       Impact factor: 9.261

7.  CHK2 stability is regulated by the E3 ubiquitin ligase SIAH2.

Authors:  C García-Limones; M Lara-Chica; C Jiménez-Jiménez; M Pérez; P Moreno; E Muñoz; M A Calzado
Journal:  Oncogene       Date:  2016-01-11       Impact factor: 9.867

8.  The combined status of ATM and p53 link tumor development with therapeutic response.

Authors:  Hai Jiang; H Christian Reinhardt; Jirina Bartkova; Johanna Tommiska; Carl Blomqvist; Heli Nevanlinna; Jiri Bartek; Michael B Yaffe; Michael T Hemann
Journal:  Genes Dev       Date:  2009-07-16       Impact factor: 11.361

9.  Alterations of Chk1 and Chk2 expression in colon cancer.

Authors:  Magdalena Stawinska; Adam Cygankiewicz; Radzislaw Trzcinski; Michal Mik; Adam Dziki; Wanda M Krajewska
Journal:  Int J Colorectal Dis       Date:  2008-08-05       Impact factor: 2.571

10.  The E3 ligase PIRH2 polyubiquitylates CHK2 and regulates its turnover.

Authors:  M Bohgaki; A Hakem; M J Halaby; T Bohgaki; Q Li; P A Bissey; J Shloush; T Kislinger; O Sanchez; Y Sheng; R Hakem
Journal:  Cell Death Differ       Date:  2013-03-01       Impact factor: 15.828

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.